Genmab A/S (GNMSF)
301.28
-0.69
(-0.23%)
USD |
OTCM |
May 17, 16:00
Genmab Price to Book Value: 4.140 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 17, 2024 | 4.140 |
May 16, 2024 | 4.149 |
May 15, 2024 | 4.006 |
May 14, 2024 | 3.954 |
May 13, 2024 | 3.863 |
May 10, 2024 | 3.991 |
May 09, 2024 | 3.908 |
May 08, 2024 | 3.824 |
May 07, 2024 | 3.901 |
May 06, 2024 | 4.075 |
May 03, 2024 | 3.981 |
May 02, 2024 | 3.803 |
May 01, 2024 | 3.752 |
April 30, 2024 | 3.772 |
April 29, 2024 | 3.742 |
April 26, 2024 | 3.774 |
April 25, 2024 | 3.723 |
April 24, 2024 | 3.857 |
April 23, 2024 | 4.006 |
April 22, 2024 | 3.996 |
April 19, 2024 | 3.926 |
April 18, 2024 | 4.015 |
April 17, 2024 | 3.885 |
April 16, 2024 | 3.942 |
April 15, 2024 | 3.899 |
Date | Value |
---|---|
April 12, 2024 | 4.025 |
April 11, 2024 | 4.127 |
April 10, 2024 | 4.121 |
April 09, 2024 | 4.097 |
April 08, 2024 | 4.041 |
April 05, 2024 | 4.059 |
April 04, 2024 | 4.118 |
April 03, 2024 | 4.049 |
April 02, 2024 | 4.150 |
April 01, 2024 | 4.098 |
March 31, 2024 | |
March 28, 2024 | 4.256 |
March 27, 2024 | 4.178 |
March 26, 2024 | 4.264 |
March 25, 2024 | 4.189 |
March 22, 2024 | 4.139 |
March 21, 2024 | 4.100 |
March 20, 2024 | 4.028 |
March 19, 2024 | 4.102 |
March 18, 2024 | 4.134 |
March 15, 2024 | 4.194 |
March 14, 2024 | 4.260 |
March 13, 2024 | 4.353 |
March 12, 2024 | 4.332 |
March 11, 2024 | 4.347 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.651
Minimum
Feb 13 2024
10.78
Maximum
Sep 04 2019
7.189
Average
7.134
Median
Jan 09 2023
Price to Book Value Benchmarks
Ascendis Pharma A/S | -- |
Galecto Inc | 0.598 |
Evaxion Biotech AS | -- |
IO Biotech Inc | 0.7874 |
Price to Book Value Related Metrics
PE Ratio | 24.97 |
PS Ratio | 7.675 |
PEG Ratio | 2.406 |
Price to Free Cash Flow | 25.38 |
Price | 301.28 |
Earnings Yield | 4.01% |
Market Cap | 19.46B |
PEGY Ratio | 2.406 |
Operating PE Ratio | 23.98 |
Normalized PE Ratio | 26.90 |